Altered tear composition in smokers and patients with graves ophthalmopathy

Archives of Ophthalmology

Volumn 124, Issue 10, 2006, Pages 1451-1456

  Baker, Glynn R C ^a   Morton, Mike ^a   Rajapaska, Rukshala S ^a   Bullock, Martyn ^a   Gullu, Sevim ^a   Mazzi, Barbara ^a   Ludgate, Marian ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; LACTOFERRIN; PROTEIN ZINC ALPHA2 GLYCOPROTEIN; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROPHORESIS; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HUMAN; LACRIMAL FLUID; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; SMOKING;

ADOLESCENT; ADULT; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EYE PROTEINS; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; MALE; MIDDLE AGED; RECEPTORS, THYROTROPIN; SMOKING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TEARS;

EID: 33749570284     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.10.1451     Document Type: Article

References (28)

1. Ludgate M, Baker G. Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin Exp Immunol. 2002;127:193-198.
2. Khalil HA, De Keizer RJ, Kijlstra A. Analysis of tear proteins in Graves' ophthalmopathy by high performance liquid chromatography. Am J Ophthalmol. 1988;106:186-190.
3. Khalil HA, De Keizer RJ, Bodelier VM, Kijlstra A. Secretory IgA and lysozyme in tears of patients with Graves' ophthalmopathy. Doc Ophthalmol. 1989;72:329-334.
4. Chang TC, Huang KM, Chang TJ, Lin SL. Correlation of orbital computer tomography and antibodies in patients with hyperthyroid Graves' disease. Clin Endocrinol (Oxf ). 1990;32:551-558.
5. Moncayo R, Baldiserra I, Decristoforo C, Kendler D, Donnemiller E. Evaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by radionuclide imaging using the somatostatin analogue 111In-octreotide. Thyroid. 1997;7:21-29.
6. Eckstein AK, Finkenrath A, Heiligenhaus A, et al. Dry eye syndrome in thyroidassociated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. Acta Ophthalmol Scand. 2004;82(3)(pt 1):291-297.
7. Tumilasci OR, Arqueros MC, Ostuni MA, el Tamer E, Houssay AB. Thyrotropin receptor antibodies in parotid saliva. J Endocrinol Invest. 1996;19(7):412-414.
8. Prummel MF, Wiersinga WM. Smoking and risk of Graves' disease. JAMA. 1993;269:479-482.
9. Metcalfe RA, Weetman AP. Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid-associated ophthalmopathy. Clin Endocrinol (Oxf). 1994;40:67-72.
10. Mack WP, Stasior GO, Cao HJ, Stasior OG, Smith TJ. The effect of cigarette smoke constituents on the expression of HLA-DR in orbital fibroblasts derived from patients with Graves ophthalmopathy. Ophthal Plast Reconstr Surg. 1999;15:260-271.
11. Smyth LJC, Machado DC, Upton AP, Good S, Aufderheide M, Helm BA. Assessment of the molecular basis of the proallergic effects of cigarette smoke. Environ Sci Technol. 2000;34:1370-1374.
12. Hufnagel TJ, Hickey WF, Cobbs WH, Jakobiec FA, Iwamoto T, Eagle RC. Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology. 1984;91:1411-1419.
13. Many MC, Costagliola S, Detrait M, Denef F, Vassart G, Ludgate MC. Development of an animal model of autoimmune thyroid eye disease. J Immunol. 1999;162:4966-4974.
14. Metcalfe R, Jordan N, Watson P, et al. Demonstration of IgG, IgA and IgE autoantibodies to the human thyrotropin receptor using flow cytometry. J Clin Endocrinol Metab. 2002;87:1754-1761.
15. Van Sande J, Massart C, Costagliola S, et al. Specific activation of the thyrotropin receptor by trypsin. Mol Cell Endocrinol. 1996;119:161-168.
16. Mourits MP, Prummel MF, Wiersinga WM, Koorneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf). 1997;47:9-14.
17. Evans C, Morgenthaler NG, Lee S, et al. Development of a luminescent bioassay for thyroid stimulating antibodies. J Clin Endocrinol Metab. 1999;84:374-376.
18. Jordan NJ, Rinderle C, Ashfield J, et al. A luminescent bioassay for thyroid blocking antibodies. Clin Endocrinol (Oxf). 2001;54:355-364.
19. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
20. Grus FH, Sabuncuo P, Augustin A, Pfeiffer N. Effect of smoking on tear proteins. Graefes Arch Clin Exp Ophthalmol. 2002;240:889-892.
21. Molloy MP, Bolis S, Herbert BR, et al. Establishment of the human reflex tear two-dimensional polyacrylamide gel electrophoresis reference map: new proteins of potential diagnostic potential. Electrophoresis. 1997;18:2811-2815.
22. Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica. 1995;80:252-267.
23. Panda K, Chattopadhyay R, Chattopadhyay D, Chatterjee IB. Cigarette smoking-induced protein oxidation and proteolysis is exclusively caused by its tar phase: prevention by vitamin C. Toxicol Lett. 2001;123:21-32.
24. Rogan MP, Taggart CC, Greene CM, Murphy PG, O'Neill SJ, McElvaney NG. Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J Infect Dis. 2004;190:1245-1253.
25. Russell ST, Zimmerman TP, Domin BA, Tisdale MJ. Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha-(2)-glycoprotein. Biochim Biophys Acta. 2004;1636:59-68.
26. Russell ST, Hirai K, Tisdale MJ. Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor. Br J Cancer. 2002;86:424-428.
27. Kelleher RS, Hann LE, Edwards JA, Sullivan DA. Endocrine, neural and immune control of secretory component output by lacrimal gland acinar cells. J Immunol. 1991;146:3405-3412.
28. Small-Howard A, Turner H. Exposure to tobacco-derived materials induces overproduction of secreted proteinases in mast cells. Toxicol Appl Pharmacol. 2005;204:152-163.